Support Just the News

Help Fund Honest Journalism


Pfizer to ask FDA for emergency use of its COVID-19 vaccine in U.S.

FDA approval could result in vaccine doses becoming ready as early as December

Updated: November 20, 2020 - 7:41am

Pharmaceutical company Pfizer said Friday it is asking federal regulators to allow emergency use of its COVID-19 vaccine.

Pfizer will make the request days after saying the company and German partner BioNTech's vaccine appeared to be 95% effective at the virus in late-stage clinical trials, according to the Associated Press.

The Food and Drug Administration can sometimes grant emergency-use authorization, before the final testing is fully complete.

Just the News Spotlight